Menu
Search
|

Menu

Close
X

Illumina Inc ILMN.OQ (NASDAQ Stock Exchange Global Select Market)

303.71 USD
-5.08 (-1.65%)
As of 4:00 PM EDT
Previous Close 308.79
Open 308.00
Volume 279,696
3m Avg Volume 386,393
Today’s High 308.00
Today’s Low 301.64
52 Week High 372.46
52 Week Low 226.00
Shares Outstanding (mil) 147.00
Market Capitalization (mil) 45,392.13
Forward P/E 55.06
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.88 Mean rating from 17 analysts

KEY STATS

Revenue (mm, USD)
FY18
3,332
FY17
2,751
FY16
2,398
EPS (USD)
FY18
5.609
FY17
5.942
FY16
3.126
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
55.06
58.10
Price to Sales (TTM)
vs sector
13.62
8.84
Price to Book (MRQ)
vs sector
12.08
4.60
Price to Cash Flow (TTM)
vs sector
46.70
40.07
Total Debt to Equity (MRQ)
vs sector
53.14
17.66
LT Debt to Equity (MRQ)
vs sector
23.68
13.97
Return on Investment (TTM)
vs sector
17.06
12.12
Return on Equity (TTM)
vs sector
25.73
13.24

EXECUTIVE LEADERSHIP

Jay Flatley
Executive Chairman of the Board, Since 2016
Salary: $771,154.00
Bonus: --
Francis deSouza
President, Chief Executive Officer, Director, Since 2016
Salary: $849,039.00
Bonus: --
Sam Samad
Chief Financial Officer, Senior Vice President, Since 2016
Salary: $425,769.00
Bonus: --
Garret Hampton
Executive Vice President - Clinical Genomics, Since 2017
Salary: $424,039.00
Bonus: $200,000.00
Omead Ostadan
Executive Vice President, Operations and Products, Since 2017
Salary: $552,512.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

5200 Illumina Way
SAN DIEGO   CA   92122-4616

Phone: +1858.2024500

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

SPONSORED STORIES